Seth A. Rudnick
Founder chez Altesa Biosciences, Inc.
Profil
Seth A.
Rudnick was the founder of Ortho Biotech, Inc. founded in 1986 where he held the position of Head-Research & Development.
He is also the founder of Altesa BioSciences, Inc. Dr. Rudnick's current jobs include Chairman at Liquidia Technologies, Inc., Director at Artizan Biosciences, Inc., Venture Partner at Pitango Venture Capital, Clinical Professor-Medicine at The University of North Carolina at Chapel Hill, Clinical Professor at The University of North Carolina at Charlotte, and Advisor at HighCape Capital Acquisition Corp.
II.
Dr. Rudnick's former jobs include Chairman & Chief Executive Officer at CytoTherapuetics, Inc., Chairman at Orthocon, Inc., Chairman at Meryx, Inc., Director at Genaissance Pharmaceuticals, Inc., Independent Director at POZEN, Inc., Director at Immunicon Corp., Director at Cylex, Inc., Director at Sopherion Therapeutics LLC, Director at CombinatoRx, Inc., Independent Director at Square 1 Financial, Inc., Director at Adlyfe, Inc., Director at Lq3 Pharmaceuticals, Inc., Director at Spine Wave, Inc., Director at VaxInnate Corp., Director at Square 1 Bank, Independent Director at G1 Therapeutics, Inc., Director at Abyrx, Inc., Director at Envisia Therapeutics, Inc., Independent Director at Old API Wind-down Ltd., Independent Director at Liquidia Corp., and Head-Pharmaceutical Development at Biogen, Inc. from 1982 to 1986.
Dr. Rudnick's education includes a doctorate from the University of Virginia in 1974 and an undergraduate degree from the University of Pennsylvania in 1969.
Postes actifs de Seth A. Rudnick
| Sociétés | Poste | Début |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Chairman | 01/01/2008 |
Artizan Biosciences, Inc.
 Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | Director/Board Member | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| The University of North Carolina at Chapel Hill | Corporate Officer/Principal | - |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2014 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Founder | - |
Pitango Venture Capital
 Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | Private Equity Investor | - |
Anciens postes connus de Seth A. Rudnick
| Sociétés | Poste | Fin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chairman | 12/06/2019 |
| LIQUIDIA CORPORATION | Director/Board Member | 28/12/2020 |
| ░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Seth A. Rudnick
| University of Virginia | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Entreprise privées | 28 |
|---|---|
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Finance |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Immunicon Corp.
 Immunicon Corp. Medical SpecialtiesHealth Technology Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA. | Health Technology |
Cylex, Inc.
 Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
| Ortho Biotech, Inc. | |
Square 1 Financial, Inc.
 Square 1 Financial, Inc. Regional BanksFinance Square 1 Financial, Inc. operates as a bank holding company for Square 1 Bank, which provides financial services to entrepreneurs and venture capitalists. It provides financial services, which includes term commercial loans, revolving lines of credit, asset-based loans, deposit products and fee-based banking services, including credit cards, foreign exchange, cash management and letters of credit. The company was founded by Casey Richard J and Casey Susan G on August 8, 2004 and is headquartered in Durham, NC. | Finance |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Adlyfe, Inc.
 Adlyfe, Inc. Medical DistributorsDistribution Services Adlyfe, Inc. is a privately held early stage biotechnology company that utilizes novel and proprietary peptide technology to develop solutions for early detection of protein misfolding diseases. It offers Pronucleon, a platform technology using custom-synthesized peptides that allow signal amplification to map the surface of rare proteins. The firm's technology detects the sequence and the conformation of amyloid proteins, to create sensitive and specific detection methods that allow early stage diagnosis and disease progression monitoring. Adlyfe was founded in 2003 by Richard O. Cliff and is headquartered in Rockville, MD. | Distribution Services |
Lq3 Pharmaceuticals, Inc.
 Lq3 Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Lq3 Pharmaceuticals, Inc. develops innovative oral health therapies. It utilizes PRINT (Particle Replication In Non-Wetting Templates) technology to research and develop solutions for an assortment of oral health issues. The firm's technology offers many advantages, such as tunable release kinetics, targeting, improved drug loading, delivery of biologics and combination products. The company was founded in 2014 and is headquartered in Garland, TX. | Health Services |
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Schering-Plough Animal Health Corp.
 Schering-Plough Animal Health Corp. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Schering-Plough Animal Health Corp. develops and manufactures pharmaceutical and biological products for food producing animals. The private company is based in Union, NJ. | Health Technology |
Spine Wave, Inc.
 Spine Wave, Inc. Medical SpecialtiesHealth Technology Spine Wave, Inc. engages in the development and commercialization of medical devices for the treatment of spinal disorders. It offers posterior platform, anterior platform, lateral platform, thoracolumbar, cervical, and biologics products. The company was founded by Mark LoGuidice and John A. Pafford in February 2001 and is headquartered in Shelton, CT. | Health Technology |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | Finance |
| CytoTherapuetics, Inc. | Finance |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Orthocon, Inc.
 Orthocon, Inc. Medical SpecialtiesHealth Technology Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY. | Health Technology |
Square 1 Bank
 Square 1 Bank Regional BanksFinance Square 1 Bank is a state chartered commercial bank. The company is based in Durham, NC. The company was founded by Christopher J. Woolley, James B. Rutter, Richard J. Casey, Robert Orr. | Finance |
Abyrx, Inc.
 Abyrx, Inc. Medical SpecialtiesHealth Technology Abyrx, Inc. develops, manufactures, and markets medical therapeutic devices. It offers montage, hemasorb, heamsorb plus, hemasorb apply, and absorbable hemostatic bone putty. The company was founded in 2013 and is headquartered in Irvington, NY. | Health Technology |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Health Technology |
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
Artizan Biosciences, Inc.
Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | Health Services |
HighCape Capital Acquisition Corp.
 HighCape Capital Acquisition Corp. Financial ConglomeratesFinance HighCape Capital Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on June 10, 2020 and is headquartered in New York, NY. | Finance |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | Finance |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Health Technology |
